Home › Non-Small Cell Lung Cancer › Wisconsin › La Crosse

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa La Crosse, WI

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa La Crosse. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Nagre-recruitPhase 2

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03191149

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3

Gundersen Lutheran Medical Center, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Gundersen Lutheran Medical Center, La Crosse

18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Gundersen Lutheran Medical Center, La Crosse
Mayo Clinic Health System-Franciscan Healthcare, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Nagre-recruitObservasyonal na pag-aaral

Gundersen Health System, La Crosse

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05236114

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa La Crosse

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.